Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, January 03, 2024
Ampersand Biomedicines has acquired AbCheck s.r.o., a technology company specializing in antibody discovery for challenging targets and formerly a wholly-owned subsidiary of Affimed GmbH. Ampersand, a multi-product platform company focused on ...
read more
Wednesday, February 05, 2020
CURE Pharmaceutical has signed an exclusive licensing agreement with ReLeaf Europe, one of Europe’s pharmaceutical groups specialized in medicinal cannabis products.
read more
EMD Millipore, the Life Science division of Merck KGaA of Germany, announced today that it will host the third annual EMD Millipore Pharma Forum on June 12, 2012, at the company’s headquarters in Darmstadt, Germany. The event will bring together ...
read more
Wednesday, November 01, 2017
The FDA has determined the agency will recognize eight European drug regulatory authorities as capable of conducting inspections of manufacturing facilities that meet FDA requirements.
read more
Cambrex announced that it is nearing the completion of a 5-year, $100-million-dollar investment strategy, one year ahead of schedule.
read more
Wednesday, November 07, 2018
Skyland Analytics has expanded UK operations with the opening of new offices in Cambridge and London and named Allan Price as Director, European Operations.
read more
Abzena has signed an agreement to support an integrated CMC program with Lipum, a company developing treatments for chronic inflammatory diseases.
read more
IVERIC bio and Catalent Biologics have entered into an agreement for production and manufacturing of GMP-grade AAV vector for IVERIC bio’s gene therapy product candidates, IC-100.
read more
Patheon has announced the appointment of Gilles Cottier as president of the company’s pharmaceutical development services (PDS) division effective immediately. He will serve as a member of Patheon’s executive committee and will report to Patheon CEO ...
read more
Thursday, September 21, 2017
Envigo has made two new appointments to its Executive Committee.
read more
Noramco and SPI Pharma have signed an agreement to develop and license a set of “value-added” formulation packages for global pharmaceutical manufacturers of finished dosage forms.
read more
Wednesday, October 09, 2019
NSF International has acquired a majority interest in Amarex Clinical Research, a clinical stage CRO headquartered in Germantown, Maryland.
read more
Monday, December 23, 2019
G-CON Manufacturing announced the expansion of its manufacturing facility for POD superstructures in College Station, TX.
read more
Catalent a global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has announced financial results for the third quarter of fiscal year 2016, which ended March 31, 2016.
read more
HealthCore, Inc. will collaborate with PCORnet, the National Patient-Centered Clinical Research Network, on building a sustainable patient-centered outcomes research network to conduct real-world comparative effectiveness research as part of a ...
read more